FindTrial
Sign In

A multicenter real-world study for the prognostic effects of different treatments for severe hyperbilirubinemia in neonates

A multicenter real-world study for the prognostic effects of different treatments for severe hyperbilirubinemia in neonates

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018360
Enrollment
Unknown
Registered
2018-09-13
Start date
2018-09-13
Completion date
Unknown
Last updated
2018-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal hyperbilirubinemia

Interventions

Group 1:exchange transfusion
Group 2:intensive phototherapy

Sponsors

West China Second University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Late premature infants and full-term newborns (= 35 weeks gestational age) who have reached the standard of exchange transfusion among the inpatients in the neonatal Department

Exclusion criteria

Exclusion criteria: 1. Failure to complete treatment for automatic discharge; 2. Incomplete data; 3. Congenital metabolic disease, chromosome inheritance, severe congenital malformation.

Design outcomes

Primary

MeasureTime frame
total bilirubin;Decrease in bilirubin;Time for bilirubin to fall below the exchange standard;Incidence of bilirubin encephalopathy;outcome;—

Secondary

MeasureTime frame
intensive phototherapy time;Normal phototherapy time;hospital day;—

Countries

China

Contacts

Public ContactTang Jun

West China Second University Hospital

tj1234753@sina.com+86 13880157106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026